Citadel Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.31M Sell
32,750
-86,450
-73% -$4.09M ﹤0.01% 7046
2025
Q4
$5.36M Buy
119,200
+101,078
+558% +$4.68M ﹤0.01% 4192
2025
Q3
$810K Buy
18,122
+815
+5% +$39K ﹤0.01% 8005
2025
Q2
$832K Buy
17,307
+9,645
+126% +$419K ﹤0.01% 7495
2025
Q1
$308K Sell
7,662
-19,366
-72% -$815K ﹤0.01% 9522
2024
Q4
$1.24M Buy
27,028
+6,611
+32% +$296K ﹤0.01% 6584
2024
Q3
$957K Sell
20,417
-783
-4% -$35.7K ﹤0.01% 6950
2024
Q2
$896K Sell
21,200
-9,360
-31% -$411K ﹤0.01% 6814
2024
Q1
$1.35M Buy
30,560
+23,864
+356% +$1.09M ﹤0.01% 6313
2023
Q4
$308K Sell
6,696
-10,468
-61% -$445K ﹤0.01% 9104
2023
Q3
$737K Buy
17,164
+15,278
+810% +$712K ﹤0.01% 7233
2023
Q2
$90.1K Sell
1,886
-943
-33% -$45.5K ﹤0.01% 11082
2023
Q1
$138K Sell
2,829
-16,787
-86% -$854K ﹤0.01% 10780
2022
Q4
$1.04M Sell
19,616
-59,412
-75% -$2.93M ﹤0.01% 6750
2022
Q3
$3.46M Buy
79,028
+62,525
+379% +$3.09M ﹤0.01% 4520
2022
Q2
$826K Sell
16,503
-34,799
-68% -$1.7M ﹤0.01% 7470
2022
Q1
$2.67M Sell
51,302
-95,060
-65% -$4.91M ﹤0.01% 5445
2021
Q4
$8.63M Buy
146,362
+18,767
+15% +$1.08M ﹤0.01% 3318
2021
Q3
$6.99M Buy
127,595
+59,318
+87% +$3.3M ﹤0.01% 3679
2021
Q2
$3.5M Sell
68,277
-22,728
-25% -$1.17M ﹤0.01% 5243
2021
Q1
$4.7M Sell
91,005
-3,866
-4% -$212K ﹤0.01% 4387
2020
Q4
$5.32M Buy
94,871
+73,464
+343% +$3.92M ﹤0.01% 3576
2020
Q3
$1.19M Sell
21,407
-22,256
-51% -$1.15M ﹤0.01% 5718
2020
Q2
$1.98M Sell
43,663
-25,934
-37% -$1.16M ﹤0.01% 4595
2020
Q1
$3.07M Sell
69,597
-6,413
-8% -$251K ﹤0.01% 3425
2019
Q4
$2.72M Buy
76,010
+68,466
+908% +$2.54M ﹤0.01% 3926
2019
Q3
$264K Sell
7,544
-9,714
-56% -$374K ﹤0.01% 7754
2019
Q2
$742K Buy
17,258
+9,053
+110% +$375K ﹤0.01% 6197
2019
Q1
$354K Sell
8,205
-6,224
-43% -$250K ﹤0.01% 7365
2018
Q4
$527K Buy
14,429
+7,167
+99% +$266K ﹤0.01% 6315
2018
Q3
$292K Buy
7,262
+566
+8% +$22.6K ﹤0.01% 7603
2018
Q2
$257K Buy
+6,696
New +$246K ﹤0.01% 7480

Other funds holding QGEN

Citadel Advisors's QGEN Position: Q1 2026 in Review

Citadel Advisors increased its Qiagen (QGEN) stake by 23% in Q1 2026, buying an estimated $4.69M and bringing the position to 531,381 shares worth $21.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

Citadel Advisors first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $96.2M in Q3 2024. 344 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Citadel Advisors held 531,381 shares of Qiagen worth $21.3M as of Q1 2026.
  • Citadel Advisors bought 99,133 Qiagen shares in Q1 2026, an estimated $4.69M.
  • Qiagen made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2264 holding.
  • Citadel Advisors first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
  • Citadel Advisors's Qiagen position peaked at $96.2M in Q3 2024.
  • 344 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.